Head-To-Head Comparison: Babylon (BBLN) versus The Competition

Babylon (NYSE:BBLN – Get Rating) is one of 33 publicly-traded companies in the “Health services” industry, but how does it weigh in compared to its competitors? We will compare Babylon to similar businesses based on the strength of its profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

Volatility and Risk

Babylon has a beta of 2.57, meaning that its stock price is 157% more volatile than the S&P 500. Comparatively, Babylon’s competitors have a beta of 1.54, meaning that their average stock price is 54% more volatile than the S&P 500.

Earnings and Valuation

This table compares Babylon and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Babylon	$1.11 billion	-$221.45 million	-0.26
Babylon Competitors	$1.47 billion	-$91.84 million	-7.22

Babylon’s competitors have higher revenue and earnings than Babylon. Babylon is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of current ratings for Babylon and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Babylon	0	2	3	0	2.60
Babylon Competitors	8	148	292	0	2.63

Babylon presently has a consensus target price of $53.08, suggesting a potential upside of 673.81%. As a group, “Health services” companies have a potential upside of 41.17%. Given Babylon’s higher probable upside, equities research analysts plainly believe Babylon is more favorable than its competitors.

Insider and Institutional Ownership

49.7% of shares of all “Health services” companies are held by institutional investors. 38.5% of Babylon shares are held by company insiders. Comparatively, 22.2% of shares of all “Health services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Babylon and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Babylon	-39.85%	-4,635.83%	-78.38%
Babylon Competitors	-118.87%	-448.95%	-28.54%

Summary

Babylon competitors beat Babylon on 7 of the 12 factors compared.

Babylon Company Profile

(Get Rating)

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.